
|Articles|October 9, 2007
Anticholesterol drug gains new name
Mipomersen sodium is the new generic name for Isis Pharmaceuticals' anticholesterol drug ISIS 301012.
Advertisement
Isis Pharmaceuticals has a new generic name for ISIS 301012, its anticholesterol drug in development. It's mipomersen sodium. The Carlsbad, Calif., firm said the drug targets apolipoprotein B-100, which is the protein that carries certain forms of cholesterol in the bloodstream. Isis hopes to offer mipomersen to patients who are unable to achieve target cholesterol levels with statins alone or who are intolerant of these drugs.
To go to the Drug Topics homepage,
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA-Approved Sunscreen Filter Bemotrizinol Debuts in New US Products
2
FDA Approves XFG-Targeted COVID-19 Vaccines From Multiple Companies
3
FDA Approves Stelara for Pediatric Ulcerative Colitis
4
COVID-19 in 2026: Why the Virus Still Threatens Vulnerable Patients
5




























